From October 1, 2023 to December 31, 2023, the company has repurchased 512,262 shares, representing 0.69% for $177.02 million. With this, the company has completed the repurchase of 1,265,661 shares, representing 1.71% for $438.34 million under the buyback announced on February 16, 2023.
West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
331.4 USD | +0.70% | -0.08% | -5.88% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.88% | 24.14B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- WST Stock
- News West Pharmaceutical Services, Inc.
- Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.